Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-04-11

Clinical Trial Update: Mechanisms of Panic Disorders Treatment [Phase 2, Phase 3]

View source ↗

Summary

This update reports on an ongoing Phase 2/Phase 3 clinical trial investigating mechanisms of treatment for panic disorder and agoraphobia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Medicine Greifswald | Conditions: Panic Disorder, Agoraphobia | Phase 2, Phase 3 | Status: UNKNOWN